#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Peter DiLaura Email
President and CEO . Initial Therapeutics
How to contact Peter DiLaura
Join and see Peter's contact info for free!Current Roles
Employees:
28Revenue:
$2.2MAbout
Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages.Initial’s approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed.Initial Therapeutics Address
285 east grand avenueSan Francisco, CA
United States